Biopharmaceutical Processing
Subscribe to Biopharmaceutical Processing

The Lead

Pipeline Advancements And Asset Acquisitions Fueled Mid-Cap Biotech R&D in 2014

April 24, 2015 11:09 am | by Global Data | News | Comments

The combined spend on research and development (R&D) for the peer group of 35 mid-cap biotech companies increased by nearly $2 billion to reach a total of $9.7 billion in 2014, primarily thanks to top spenders Regeneron and Vertex, says research and consulting firm GlobalData.

Hospira Recalls One Lot Of Bupivacaine HCl Injection

April 24, 2015 11:02 am | by U.S. Food And Drug Administration | News | Comments

Hospira is issuing a voluntary recall of one lot of Preservative-Free Bupivacaine HCl Injection...

Mylan Launches Generic Sofosbuvir Tablets, MyHep, in India

April 23, 2015 10:30 am | by PRNewswire | News | Comments

The product is indicated for the treatment of chronic hepatitis C, a blood-borne infectious...

Oral Therapies The Next Step For Rheumatoid Arthritis

April 23, 2015 10:22 am | by Frost & Sullivan | News | Comments

The market for other rheumatoid arthritis therapeutics is considerable as many patients do not...

View Sample

FREE Email Newsletter

McCormack Pharma's Discovery Could Mean New Guidelines For Anti-Platelet Drug Use

April 23, 2015 10:16 am | by PRNewswire | News | Comments

Clopidogrel (Plavix) is an anti-platelet drug that is used to prevent the formation of a thrombus (clot) in vulnerable patients. However, a significant proportion of patients who receive clopidogrel remain at risk for subsequent death, myocardial infarction, stent thrombosis, and stroke because of insufficient clopidogrel-induced platelet inhibition.

Study: Drug Successfully Treats Ebola Strain

April 23, 2015 10:07 am | by Andy Szal, Digital Reporter | News | Comments

Researchers then gave the TKM-Ebola-Makona drug to three of the monkeys, each of whom developed milder symptoms and fully recovered from the disease.

Astellas And Potenza Partner to Create Immuno-Oncology Therapeutics

April 22, 2015 11:25 am | by PRNewswire | News | Comments

Astellas Pharma Inc. and Potenza Therapeutics, Inc., a biotechnology company developing a portfolio of immuno-oncology programs, today announced an exclusive research and development collaboration. 


Marrone Bio Expands Research And Development Capacity

April 22, 2015 11:00 am | by Globe Newswire | News | Comments

Marrone Bio Innovations, Inc., a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets, today announced the opening of its new greenhouse to facilitate and expand its research and product development capacity.

ITT Showcases Valve And Pump Technologies at INTERPHEX

April 21, 2015 11:19 am | by ITT | News | Comments

ITT Corporation is showcasing its highly engineered valve technologies and solutions at Interphex, one of the world's largest trade shows for the biopharmaceutical industry.

SCHOTT to Demonstrate Vials at Interphex 2015

April 21, 2015 11:13 am | News | Comments

For the first time, the company will also be presenting a polymer prefillable syringe for sensitive drugs – the new SCHOTT TopPac SD.

Eli Lilly Biomanufacturing Plant For Sale

April 21, 2015 10:54 am | News | Comments

CBRE Group, Inc. announced today that they have been hired to sell Eli Lilly’s biomanufacturing plant in Vacaville, California.

Drug R&D Costs: $1.7 Billion And Rising

April 20, 2015 10:44 am | by Institute For Policy Innovation | News | Comments

Growing costs have been attributed to a slow FDA, drug complexity, and short patent life.


NeoStem Announces Expanded Cell Therapy Manufacturing Relationship With Kite Pharma

April 20, 2015 10:25 am | by Globe Newswire | News | Comments

NeoStem, Inc., a biopharmaceutical company developing novel cell-based individualized medicine therapies, announced today the expansion of manufacturing services under an existing Services Agreement between its wholly-owned subsidiary, PCT, and Kite Pharma.

Could Maple Syrup Help Cut Use of Antibiotics?

April 17, 2015 3:41 pm | by McGill University | Articles | Comments

Syrup extract found to make antibiotics more effective against bacteria.

Glaxo Recalls Flu Vaccine Due to Potency Problem

April 17, 2015 3:37 pm | by MATTHEW PERRONE, AP Health Writer | News | Comments

The company alerted U.S. customers Tuesday that the vaccine can lose potency and fail to adequately protect against some strains of the flu.

Sartorius Stedim Biotech Acquires BioOutsource

April 17, 2015 12:10 pm | by Sartorius Stedim Biotech Group | News | Comments

Sartorius Stedim Biotech (SSB), an international supplier for the biopharmaceutical industries, today acquired the Scottish company BioOutsource Ltd.

Catalent Announces $52 Million Kentucky Expansion

April 16, 2015 11:01 am | by Catalent Pharma Solutions | News | Comments

Catalent Pharma Solutions announced the opening of a large scale expansion at its Winchester, KY, manufacturing facility.


Actinium Doses The First Patient in The Fourth, Final Cohort of Its Actimab-A Trial

April 15, 2015 3:20 pm | by Actinium Pharmaceuticals | News | Comments

Actinium Pharmaceuticals, Inc., a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, announced that the first patient was successfully treated with Actimab-A drug candidate in the fourth and last cohort of the ongoing Phase 1/2 trial of Actimab-A.

ACG North America Bringing Manufacturing, Packaging And Inspection Technology to INTERPHEX

April 15, 2015 3:13 pm | by ACG North America | News | Comments

International Pharmaceutical Expo, the premier industry event dedicated to showcasing pharmaceutical and biopharmaceutical innovation, technology and knowledge, today announced ACG North America will feature their line of end-to-end oral solid dosage manufacturing, packaging and inspection technologies, at INTERPHEX 2015.

Rentschler Biotechnologie Expands Biopharm Capabilities

April 14, 2015 11:28 am | by GE Healthcare | News | Comments

GE Healthcare Life Sciences and Rentschler Biotechnologie GmbH announced the expansion of Rentschler’s biopharmaceutical manufacturing capabilities.

Watson-Marlow Acquires ASEPCO Corporation

April 10, 2015 12:29 pm | by Watson-Marlow Fluid Technology Group (WMFTG) | News | Comments

Watson-Marlow Fluid Technology Group strengthens its biopharmaceutical offering through the acquisition of ASEPCO Corporation (Asepco).

Can Cancer Vaccines Prolong Survival?

April 6, 2015 4:05 pm | by Mary Ann Liebert, Inc. / Genetic Engineering News | News | Comments

Therapeutic anti-cancer vaccines rarely have a noticeable effect on the tumor but have been associated with a statistically significant increase in patient survival. 

Microbix Signs Virology Distribution Agreement for South Korea

April 6, 2015 12:23 pm | News | Comments

Microbix Biosystems has signed an exclusive distribution agreement with Kim & Friends, Inc. The agreement provides Microbix with improved access to the key South Korean market for its virology products.

Cellceutix Enters $30 Million Common Stock Purchase Agreement

April 2, 2015 1:19 pm | by Cellceutix Corporation | News | Comments

Cellceutix Corporation, a clinical stage biopharmaceutical company, has signed a $30 million stock purchase agreement with Aspire Capital Fund, LLC.

Patheon Closes Acquisition of IRIX Pharmaceuticals

April 1, 2015 12:33 pm | by Patheon | News | Comments

Patheon has closed the transaction to acquire IRIX Pharmaceuticals, a company that specializes in making difficult to manufacture Active Pharmaceutical Ingredients (API).

Althea's New Drug Formulation Technology Gains Attention

March 31, 2015 12:01 pm | News | Comments

Ajinomoto Althea announced today that it has added two more top pharmaceutical companies to its growing list of partners in developing and manufacturing cGMP-produced crystal-based drug products.

Developing Flexibility and Efficiency in Biomanufacturing Facilities

March 27, 2015 8:05 am | by Jeff Odum, CPIP, Biopharmaceutical Market Leader, IPS | News | Comments

Current developments in the biopharmaceutical industry have added significantly to the challenges of designing, building, and operating biopharmaceutical manufacturing facilities.

Genentech Announces Plans to Expand Hillsboro Facility

March 26, 2015 3:26 pm | News | Comments

Genentech, a member of the Roche Group, has announced plans to invest more than $125 million for the expansion of its fill/finish facility in Hillsboro, Oregon.

Managing the SUS-Based Facility Design

March 25, 2015 8:31 am | by Jeff Odum, CPIP, IPS-Integrated Project Services, Inc. | Blogs | Comments

There are many nuances that require a more focused approach to risk identification and project management for the “new” manufacturing facilities implementing Single-use Systems (SUS). 

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.